These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24077559)

  • 1. Anti-leishmanial activity of heteroleptic organometallic Sb(v) compounds.
    Ali MI; Rauf MK; Badshah A; Kumar I; Forsyth CM; Junk PC; Kedzierski L; Andrews PC
    Dalton Trans; 2013 Dec; 42(48):16733-41. PubMed ID: 24077559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability and toxicity of tris-tolyl bismuth(V) dicarboxylates and their biological activity towards Leishmania major.
    Ong YC; Blair VL; Kedzierski L; Tuck KL; Andrews PC
    Dalton Trans; 2015 Nov; 44(41):18215-26. PubMed ID: 26425978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of new combination anti-leishmanial complexes: Triphenyl Sb(V) mono-hydroxy mono-quinolinolates.
    Duffin RN; Blair VL; Kedzierski L; Andrews PC
    J Inorg Biochem; 2021 Jun; 219():111385. PubMed ID: 33894637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative stability, toxicity and anti-leishmanial activity of triphenyl antimony(v) and bismuth(v) α-hydroxy carboxylato complexes.
    Duffin RN; Blair VL; Kedzierski L; Andrews PC
    Dalton Trans; 2018 Jan; 47(3):971-980. PubMed ID: 29260831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative stability, cytotoxicity and anti-leishmanial activity of analogous organometallic Sb(V) and Bi(V) acetato complexes: Sb confirms potential while Bi fails the test.
    Duffin RN; Blair VL; Kedzierski L; Andrews PC
    J Inorg Biochem; 2018 Dec; 189():151-162. PubMed ID: 30267965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability and toxicity of heteroleptic organometallic Bi(V) complexes towards Leishmania major.
    Ong YC; Blair VL; Kedzierski L; Andrews PC
    Dalton Trans; 2014 Sep; 43(34):12904-16. PubMed ID: 25019320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Leishmanial activity of homo- and heteroleptic bismuth(III) carboxylates.
    Andrews PC; Frank R; Junk PC; Kedzierski L; Kumar I; MacLellan JG
    J Inorg Biochem; 2011 Mar; 105(3):454-61. PubMed ID: 20851471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoscaled hydrated antimony (V) oxide as a new approach to first-line antileishmanial drugs.
    Franco AM; Grafova I; Soares FV; Gentile G; Wyrepkowski CD; Bolson MA; Sargentini É; Carfagna C; Leskelä M; Grafov A
    Int J Nanomedicine; 2016; 11():6771-6780. PubMed ID: 28008252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to antimony and treatment failure in human Leishmania (Viannia) infection.
    Rojas R; Valderrama L; Valderrama M; Varona MX; Ouellette M; Saravia NG
    J Infect Dis; 2006 May; 193(10):1375-83. PubMed ID: 16619185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complexes of different nitrogen donor heterocyclic ligands with SbCl3 and PhSbCl2 as potential antileishmanial agents against Sb(III)-sensitive and -resistant parasites.
    Lizarazo-Jaimes EH; Reis PG; Bezerra FM; Rodrigues BL; Monte-Neto RL; Melo MN; Frézard F; Demicheli C
    J Inorg Biochem; 2014 Mar; 132():30-6. PubMed ID: 24412095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neolignan Licarin A presents effect against Leishmania (Leishmania) major associated with immunomodulation in vitro.
    Néris PL; Caldas JP; Rodrigues YK; Amorim FM; Leite JA; Rodrigues-Mascarenhas S; Barbosa-Filho JM; Rodrigues LC; Oliveira MR
    Exp Parasitol; 2013 Oct; 135(2):307-13. PubMed ID: 23891943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulating aryl substitution: Does it play a role in the anti-leishmanial activity of a series of tetra-aryl Sb(V) fluorinated carboxylates?
    Artem'eva EV; Duffin RN; Munuganti S; Efremov AN; Andrews PC; Sharutina OK; Sharutin VV
    J Inorg Biochem; 2022 Sep; 234():111864. PubMed ID: 35636013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-leishmanial activity and cytotoxicity of a series of tris-aryl Sb(V) mandelate cyclometallate complexes.
    Duffin RN; Blair VL; Kedzierski L; Andrews PC
    J Inorg Biochem; 2020 Feb; 203():110932. PubMed ID: 31790875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antileishmanial activity of ruthenium(II)tetraammine nitrosyl complexes.
    Pereira JC; Carregaro V; Costa DL; da Silva JS; Cunha FQ; Franco DW
    Eur J Med Chem; 2010 Sep; 45(9):4180-7. PubMed ID: 20598778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of antimony in rhesus monkeys infected with Leishmania braziliensis and treated with meglumine antimoniate.
    Friedrich K; Vieira FA; Porrozzi R; Marchevsky RS; Miekeley N; Grimaldi G; Paumgartten FJ
    J Toxicol Environ Health A; 2012; 75(2):63-75. PubMed ID: 22129235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of antimony complexes of yeast mannan and mannan derivatives and their effect on Leishmania-infected macrophages.
    Cantos G; Barbieri CL; Iacomini M; Gorin PA; Travassos LR
    Biochem J; 1993 Jan; 289 ( Pt 1)(Pt 1):155-60. PubMed ID: 8424752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and characterization of bismuth(III) and antimony(V) porphyrins: high antileishmanial activity against antimony-resistant parasite.
    Gomes ML; DeFreitas-Silva G; dos Reis PG; Melo MN; Frézard F; Demicheli C; Idemori YM
    J Biol Inorg Chem; 2015 Jul; 20(5):771-9. PubMed ID: 25929728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimonial susceptibility and in vivo behaviour of Leishmania major isolates collected in Algeria before and after treatment.
    Naouel E; Ihcene KD; Sofiane B; Khatima AO; Razika B; Bruno O; Zoubir H; Denis S
    Acta Trop; 2018 Apr; 180():7-11. PubMed ID: 29278674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation on the pharmacological profile of antimony(III) complexes with hydroxyquinoline derivatives: anti-trypanosomal activity and cytotoxicity against human leukemia cell lines.
    Reis DC; Pinto MC; Souza-Fagundes EM; Rocha LF; Pereira VR; Melo CM; Beraldo H
    Biometals; 2011 Aug; 24(4):595-601. PubMed ID: 21221718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis.
    Azeredo-Coutinho RB; Mendonça SC; Callahan H; Portal AC; Max G
    J Parasitol; 2007 Jun; 93(3):688-93. PubMed ID: 17626365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.